Zhitong Technology has successfully concluded a Series A+ funding round, securing tens of millions of yuan. The funds will be dedicated to advancing visual imaging and intelligent technology tailored for microscopic surgical applications. The company has introduced a diverse portfolio of three categories and six high-end domestic microscopic imaging and intelligent series products, including state-of-the-art 3D external vision microscopic systems. These products have earned a national innovation medical device registration certificate, propelling surgical operations towards unprecedented levels of refinement and precision. Currently, they are installed in numerous hospitals across China and have made successful inroads into international markets. The founding team of Zhitong Technology boasts roots in a collaborative project between Tsinghua University and the People's Liberation Army General Hospital, endowing them with comprehensive independent research and development capabilities spanning optics, machinery, and imaging. This latest round of funding was led by Hetang Venture Capital, with Kai Cheng Capital serving as the financial advisor. Both parties express optimism regarding Zhitong Technology's robust technical capabilities and promising development prospects.